水杉愈伤组织诱导及植株再生

通过愈伤组织诱导器官发生途径,建立了水杉（Metasequoia glyptostroboides）的植株再生体系,探讨了不同外植体（种胚、幼叶切块、茎段、根段）和植物生长调节剂对不定芽直接再生和愈伤组织诱导器官发生的影响。结果表明：以种胚、无菌苗叶片、茎段和根作为外植体,在MS补加2,4-D、NAA和6-BA不同组合的培养基上都能诱导得到愈伤组织,其中种胚诱导愈伤组织效果最好,诱导率可达100%,茎诱导效果次之,诱导率为97.1%。诱导愈伤组织效果较好的培养基有：MS＋1.0mg·L-12,4-D＋0.5mg·L-16-BA、MS＋0.1mg·L-16-BA＋1.0mg·L-1NAA、MS＋0.5mg·L-16-BA＋1.0mg·L-1NAA、MS＋1.0mg·L-16-BA＋1.0mg·L-1NAA、MS＋0.5mg·L-16-BA＋2.0mg·L-1NAA、MS＋1.0mg·L-16-BA＋2.0mg·L-1NAA和MS＋0.5mg·L-12,4-D＋0.5mg·L-1NAA。以愈伤组织在MS培养基上植株再生效果最好,再生率为62.5%。     

海南粗榧愈伤组织的诱导和培养

海南粗榧的嫩茎和嫩叶以0.1%升汞消毒12 min的效果最好.外植体在MS 0.1 mg·L.6-BA l mg·L-1NAA 2mg·L-12,4-D 3.0%蔗糖 0.6%卡拉胶(pH 5.8)培养基中能顺利诱导出愈伤组织.液体悬浮和暗培养均有利于愈伤组织的增殖.愈伤组织增殖的最佳培养基为MS 0.1 mg·L-1KT 3 mg·L-1NAA 3.0%蔗糖(pH 5.8).     

亚麻品种'双亚5号'的胚性愈伤组织诱导和体细胞胚胎发生

亚麻品种'双亚5号'的种子在MS 1.0 mg·L-1 2,4-D 30 g·L-1蔗糖培养基上可诱导出愈伤组织,将其转入MS 0.5mg·L-1KT 0.5mg·L-1NAA培养基上培养10周后诱导出大量胚性愈伤组织,结构较致密,浅黄色,表面有成团的紧密粘附在一起的小颗粒形态.但其继代周期不宜太长,继代次数不宜多,否则易回到非胚性化状态.胚性愈伤组织转A.MS 1.5 mg·L-1(T 1.0 mg·L-1 2,4-D分化培养基上培养40 d后可获得大量的球形胚状体.少量球形体胚可萌发形成正常的子叶胚初期形态,较多的球形体胚形成次生体胚或仅有单极性的畸形胚状体.组织解剖学观察表明,诱导出的是亚麻胚性愈伤组织和胚状体.     

影响茎用芥菜愈伤组织诱导和植株再生的因素

茎用芥菜子叶培养在MS 0.25 mg·L-1NAA 0.5 mg·L-16-BA 0.25 mg·L-12,4-D培养基上,可获得较高质量的愈伤组织.愈伤组织培养在MS 1～1 mg·L-16-BA 0.2 mg·L-1NAA培养基上分化频率为8.3%,而在加有羧苄青霉素和头孢霉素的培养基上,最高分化频率可达52.4%.将获得的再生植株转移到1/2MS 0.1 mg·L-1 NAA的生根培养基中,可获得完整植株.     

结缕草再生体系的研究

以结缕草品种‘Zenith’(Zoysia japonica‘Zenith’)的种子为外植体,在附加1.0 mg.L-12,4-D和0.1mg.L-16-BA或2.0 mg.L-12,4-D的MS培养基上培养,愈伤组织诱导率较高,分别达到100%和92%。在添加了2.0 mg.L-12,4-D或1.0 mg.L-12,4-D和0.1 mg.L-16-BA的MS培养基上继代培养可诱导出胚性愈伤组织,诱导率分别为3.26%和14.52%。胚性愈伤组织在含0.01mg.L-12,4-D的1/2 MS分化培养基上的分化率和生根率都达到100%。     

白刺花胚性愈伤组织诱导及体细胞胚发生和萌发

探讨不同因素对白刺花下胚轴、子叶2种外植体胚性愈伤组织诱导及体细胞胚发生和萌发的影响。以B5和MS为基本培养基,研究2,4-D、6-BA和TDZ对白刺花下胚轴和子叶胚性愈伤组织的诱导;在MS培养基上添加不同浓度2,4-D,研究胚性愈伤组织增殖情况;采用ABA,探究对体细胞胚发生的影响。结果表明:下胚轴比子叶更易诱导胚性愈伤组织,筛选出2种外植最佳的胚性愈伤组织诱导培养基均为MS+2.0 mg/L 2,4-D+0.5 mg/L TDZ+0.5 mg/L 6-BA,胚性愈伤组织诱导率分别为77.3%和41.0%。15.0 mg/L ABA、0.2 mg/L 2,4-D和2.0 mg/L 6-BA有利于体细胞胚发生,1/3MS+0.2 mg/L NAA+0.1 mg/L 6-BA+2.0 g/L活性炭+25 g/L蔗糖+7 g/L琼脂的培养基可使体细胞胚萌发率达80%以上,再生植株移栽成活率高达90%。白刺花外植体种类及培养基类型均会影响胚性愈伤组织的诱导,其中下胚轴诱导效果优于子叶;MS培养基较适合启动细胞脱分化形成愈伤组织,2,4-D对胚性愈伤组织的增殖保持有调控作用,ABA有利于体细胞胚的发生。     

芒属植物荻愈伤组织的诱导与植株再生

利用资源植物荻(Miscanthus sacchariflorus)的幼穗作为外植体,通过愈伤组织途径建立了植株再生体系.结果表明:在附加600 mg·L-1脯氨酸、500 mg·L-1水解酪蛋白、2.0mg ·L-12,4-D和0.1mg·L-16-BA的MS培养基上能高效诱导出生长良好的愈伤组织;将其转移到MS+1.5 mg·L-1 6-BA培养基上诱导产生芽,再转移到1/2 MS+0.25 mg·L-1 NAA+0.25 mg·L-1 IAA培养基上生根后,可发育为生长健壮的植株.     

油茶优良无性系子叶体细胞胚植株再生

以油茶优良无性系‘湘林4号’子叶为外植体,采用附加不同种类激素的MS培养基对其进行组织培养实验。研究结果表明:子叶形成胚性愈伤组织的最适合培养基为MS+2.0mg.L-12,4-D+1.0mg.L-1KT;经胚状体诱导产生不定芽分化的最适合培养基为MS+2.5mg.L-16-BA+1.5mg.L-1IAA;油茶优良无性系的生根培养基以MS+7.0mg.L-1NAA最适;通过对植株再生过程中各阶段的组培材料进行RAPD鉴定分析表明,DNA水平上未发现变异,说明通过组织培养建立的油茶优良无性系再生植株同原无性系无明显差别,最终获得的组培苗木能够保持原无性系的优良特性,其遗传是稳定的。     

芨芨草愈伤组织器官发生及植株再生

芨芨草(Achnatherum splendens(Trin.)Nevski)种子消毒并在MS培养基上萌发获得无菌苗,以幼苗的叶鞘和胚轴为外植体诱导愈伤组织,经继代后进一步诱导不定芽及生根.研究结果表明,诱导愈伤组织最适合的培养基为B5 1.5 mg·L-12,4-D 0.5 mg·L-1NAA;诱导芽分化较适合的培养基为B5 0.5 mg·L-1 6-BA 0.2 mg·L-1 NAA;1/4B5 1.0 mg·L-1NAA 0.2 mg·L-1 IBA 1.0 g·L-1活性炭培养基则有利于芨芨草试管苗的生根.本实验建立了完整的芨芨草植株再生体系,移栽成活率高.     

杂交狼尾草胚性愈伤组织的诱导与植株再生

以杂交狼尾草初级愈伤为材料,运用方差分析的方法研究不同因素对杂交狼尾草胚性愈伤诱导率与植株再生率的影响。结果发现,2,4-D和TDZ对杂交狼尾草胚性愈伤诱导影响显著,最佳的胚性愈伤诱导培养基为MS+3.0 mg·L-12,4-D+0.4 mg·L-16-BA+0.2 mg·L-1 TDZ,诱导率为54%;愈伤分化培养基以附加0.1 mg·L-1 TDZ+0.2 mg·L-16-BA+3.2 mg·L-1 CuSO4的 MS培养基为最佳,再生率为68.33%,褐化率为8.33%;分化培养基中添加0.8~3.2mg·L-1的CuSO4均能促进杂交狼尾草愈伤组织分化,而添加AgNO3对杂交狼尾草愈伤分化无显著影响。该技术为离体诱变获得杂交狼尾草低温种质材料奠定了基础。     

Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis

It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

Comparative morphology of the carpel in the Liliaceae: Hewardieae, Petrosavieae, and Tricyrteae

The young pistils in the melanthioid tribes, Hewardieae, Petrosavieae and Tricyrteae, are uniformly tricarpellate and syncarpous. They lack raphide idioblasts. All are multiovulate, with bitegmic ovules. The Petrosavieae are marked by the presence of septal glands and incomplete syncarpy. Tepals and stamens adhere to the ovary in the Hewardieae and the Petrosavieae but not in the Tricyrteae. Two vascular bundles occur in the stamens of the Hewartlieae and Tricyrtis latifolia. Ventral bundles in the upper part of the ovary of the Hewardieae are continuous with compound septal bundles and placental bundles in the lower part. Putative ventral bundles occur in the alternate position in the Tricyrteae and putative placental bundles in the opposite. position in the Petrosavieae. The dichtomously branched stigma in each carpel of the Tricyrteae is supplied by a bifurcated dorsal bundle.     

Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid

Microbial resistance to antibiotics is an unresolved global concern, which needs urgent and coordinated action. One of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat antibiotic resistance is the development of new antibiotics to treat drug-resistant bacteria. In our effort to find new antibiotics, we report the synthesis and antimicrobial studies of 30 new pyrazole derivatives. These novel molecules have been synthesized by using readily available starting materials and benign reaction conditions. Some of these molecules have shown activity with MIC values as low as 0.78?µg/mL against four bacterial strains; Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, and Acinetobacter baumannii. Furthermore, active molecules are non-toxic to mammalian cell line.

     

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Cyclin-dependent kinases (CDKs) and Polo-like kinases (PLKs) play key role in the regulation of the cell cycle. The aim of our study was originally the further development of our recently discovered polo-like kinase 1 (PLK1) inhibitors. A series of new 2,4-disubstituted pyrimidine derivatives were synthesized around the original hit, but their PLK1 inhibitory activity was very poor. However the novel compounds showed nanomolar CDK9 inhibitory activity and very good antiproliferative effect on multiple myeloma cell lines (RPMI-8226).